COMP <GO>
WHWK vs TRDA // DIVIDEND YIELD & FCF PAYOUT SAFETY
Whitehawk Therapeutics Inc. (NASDAQ) VS. Entrada Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: WHWK 4
— TRDA 0
■ METRIC PARITY
LAST: $3.12 (-3.70%) • MKT CAP: $184.7M
dividend-safety
0.00%
LAST: $5.11 (+12.68%) • MKT CAP: $176.6M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WHWK VS. TRDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WHWK | TRDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 89.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | -65.00% | 0.00 | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.11 | 0.20 | +2.91 | WHWK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | WHWK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.9 | 40.9 | +2.00 | WHWK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $184.7M | $176.6M | $8.1M | WHWK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WHWK REV | TRDA REV | WHWK GROSS % | TRDA GROSS % | WHWK FCF | TRDA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.1M | $25.4M | 89.4% | — | -$98.0M | -$129.6M |
| FY 2024 | $26.0M | $210.8M | 88.4% | — | -$61.2M | -$44.7M |
| FY 2023 | $24.4M | $129.0M | — | — | -$59.7M | $139.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WHWK // BETA —
TRDA // BETA —